Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: a phase III randomized trial-Reference-Cited by-同舟云学术

Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: a phase III randomized trial

Published:2003-09 Issue:3 Volume:41 Page:321-331
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Zatloukal Petr,Petruželka Luboš,Zemanová Milada,Kolek Vı́tězslav,Skřičková Jana,Pešek Miloš,Fojtů Hana,Grygárková Ivona,Sixtová Dimka,Roubec Jaromı́r,Hořenková Eva,Havel Libor,Průša Petr,Nováková Leona,Skácel Tomáš,Kůta Milan

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference49 articles.

1. Anonymous: chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials;BMJ,1995

2. Chemotherapy for advanced non-small cell lung cancer. How much benefit is enough?;Grilli;J. Clin. Oncol.,1993

3. Non-small cell lung cancer. An overview of current management;Dancey;EJC,1997

4. Gemcitabine: a pharmacologic and clinical overview;Barton-Burke;Cancer Nurs.,1999

5. Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase II study;Abratt;J. Clin. Oncol.,1994

Cited by 147 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and efficacy of SNK01 (autologous natural killer cells) in combination with cytotoxic chemotherapy and/or cetuximab after failure of prior tyrosine kinase inhibitor in non-small cell lung cancer: non-clinical mouse model and phase I/IIa clinical study;Journal for ImmunoTherapy of Cancer;2024-03

2. Enhancer mutations modulate the severity of chemotherapy-induced myelosuppression;Life Science Alliance;2024-01-16

3. Self-assembly of Hyaluronic Acid-Cu-Quercetin flavonoid nanoparticles: synergistic chemotherapy to target tumors;PeerJ;2023-08-28

4. Off-label despite high-level evidence: a clinical practice review of commonly used off-patent cancer medicines;ESMO Open;2023-02

5. The association of four genetic variants with myelosuppression in gemcitabine‐treated Japanese is not evident in gemcitabine/carboplatin‐treated Swedes;Basic & Clinical Pharmacology & Toxicology;2022-02-14